Home › The Long-Term Investment Case For Amgen
 

Keywords :   


The Long-Term Investment Case For Amgen

2015-10-11 11:18:04| Biotech - Topix.net

Biotech pioneer Amgen has been caught in the recent bear market that has swept over the Biotech Land over the past couple of months. The stock is down ~$30.00 a share from the recent highs even as the company has seen some positive catalysts over that time frame.

Tags: case investment longterm amgen

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
08.11Sheboygan Paint Company Names New Regional Sales Managers
08.11Irritants could disrupt U.S., Mexico trade relationship
08.11Irritants could disrupt U.S., Mexico trade relationship
08.11Atlantic Tropical Weather Outlook
08.11Eastern North Pacific Tropical Weather Outlook
08.11African swine fever, labor and trade top of mind for Canadian pork industry
08.11Tech giants dominate U.S. streaming platform market
08.11Warner Bros. Discovery adds 7.2 million DTC subscribers in 3Q 2024
More »